IVD RAW MATERIALS MARKET ANALYSIS
Global IVD Raw Materials Market: Key Developments
In June 2022, Medix Biochemica (Espoo, Finland) acquired 100% of the shares of Bioresource Technology to broaden its base matrix capabilities and further strengthen its local presence in the US market. Medix will provide its customers with a comprehensive offering of raw materials for their in vitro diagnostics (IVD) quality control products.
In March 2022, Medix Biochemica announced the launch of rejuvenated brand to reflect both the improvements to its offering as a result of recent acquisitions, and its ongoing commitment to the in vitro diagnostics (IVD) industry. The company hopes that its accelerated growth will establish its status as the ultimate IVD raw materials supplier.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
